Cargando…
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
We aim to determine the feasibility of a novel radiomic biomarker that can integrate with other established clinical prognostic factors to predict progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) undergoing first-line immunotherapy. Our study includes 107 patients...
Autores principales: | Singh, Apurva, Horng, Hannah, Roshkovan, Leonid, Weeks, Joanna K., Hershman, Michelle, Noël, Peter, Luna, José Marcio, Cohen, Eric A., Pantalone, Lauren, Shinohara, Russell T., Bauml, Joshua M., Thompson, Jeffrey C., Aggarwal, Charu, Carpenter, Erica L., Katz, Sharyn I., Kontos, Despina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200843/ https://www.ncbi.nlm.nih.gov/pubmed/35705618 http://dx.doi.org/10.1038/s41598-022-14160-7 |
Ejemplares similares
-
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography
por: Hershman, Michelle, et al.
Publicado: (2021) -
Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023) -
Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation
por: Luna, José Marcio, et al.
Publicado: (2022) -
Resampling and harmonization for mitigation of heterogeneity in image parameters of baseline scans
por: Singh, Apurva, et al.
Publicado: (2022) -
Improved generalized ComBat methods for harmonization of radiomic features
por: Horng, Hannah, et al.
Publicado: (2022)